Literature DB >> 23861108

Betaine protects against high-fat-diet-induced liver injury by inhibition of high-mobility group box 1 and Toll-like receptor 4 expression in rats.

Wei Zhang1, Lu-Wen Wang, Li-Kun Wang, Xun Li, Hong Zhang, Li-Ping Luo, Jin-Chun Song, Zuo-Jiong Gong.   

Abstract

BACKGROUND AND OBJECTIVES: Previous studies have shown that betaine prevents alcohol-induced liver injury and improves liver function. The purpose of this study was to investigate the hepatoprotective effects of betaine on nonalcoholic fatty liver disease (NAFLD) and to observe changes of HMGB1/TLR4 signaling.
METHODS: Thirty rats were randomly divided into control, model, and betaine groups. The rats in the model and betaine groups were fed a high-fat diet for 12 weeks to induce an animal model of NAFLD. The rats in the betaine group were then intragastrically administered betaine solution at a dose of 400 mg/kg per day for four weeks. Liver histology was examined. Serum levels of ALT, AST, TC, TG, HDL-C, LDL-C, FFA, HMGB1, NF-κB, TLR4, and tHcy were determined and intrahepatic TC, TG, and Hcy levels were assayed. mRNA expression and protein levels of HMGB1, NF-κB, and TLR4 in liver tissue were also determined.
RESULTS: Compared with the control group, rats in the model group developed severe liver injury, accompanied by significant increases in serum levels of ALT, AST, TC, TG, LDL-C, FFA, HMGB1, NF-κB, and TLR4, intrahepatic TC, TG, and Hcy content, histological scores for steatosis, inflammation, and necrosis, and mRNA expression and protein levels of HMGB1, NF-κB, and TLR4, and a significant decrease in serum HDL-C (P < 0.05). Compared with the model group, all these indicators were significantly improved by administration of betaine (P < 0.05).
CONCLUSIONS: Betaine effectively protects against high-fat-diet-induced NAFLD and improves liver function; the mechanism is probably related to inhibition of HMGB1/TLR4 signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23861108     DOI: 10.1007/s10620-013-2775-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

Review 1.  From fat to inflammation.

Authors:  Christopher Paul Day
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

2.  TLR4 links innate immunity and fatty acid-induced insulin resistance.

Authors:  Hang Shi; Maia V Kokoeva; Karen Inouye; Iphigenia Tzameli; Huali Yin; Jeffrey S Flier
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

3.  The glucose-6 phosphatase gene is expressed in human and rat small intestine: regulation of expression in fasted and diabetic rats.

Authors:  F Rajas; N Bruni; S Montano; C Zitoun; G Mithieux
Journal:  Gastroenterology       Date:  1999-07       Impact factor: 22.682

4.  NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis.

Authors:  Aileen Dela Peña; Isabelle Leclercq; Jacqueline Field; Jacob George; Brett Jones; Geoffrey Farrell
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

5.  IKK-beta links inflammation to obesity-induced insulin resistance.

Authors:  Melek C Arkan; Andrea L Hevener; Florian R Greten; Shin Maeda; Zhi-Wei Li; Jeffrey M Long; Anthony Wynshaw-Boris; Giuseppe Poli; Jerrold Olefsky; Michael Karin
Journal:  Nat Med       Date:  2005-01-30       Impact factor: 53.440

6.  Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation.

Authors:  P Yi; S Melnyk; M Pogribna; I P Pogribny; R J Hine; S J James
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

7.  Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia.

Authors:  Mohamed Lamkanfi; Anasuya Sarkar; Lieselotte Vande Walle; Alberto C Vitari; Amal O Amer; Mark D Wewers; Kevin J Tracey; Thirumala-Devi Kanneganti; Vishva M Dixit
Journal:  J Immunol       Date:  2010-08-27       Impact factor: 5.422

8.  Toll-like receptors as targets in chronic liver diseases.

Authors:  A Mencin; J Kluwe; R F Schwabe
Journal:  Gut       Date:  2009-05       Impact factor: 23.059

9.  Effect of transgenic extrahepatic expression of betaine-homocysteine methyltransferase on alcohol or homocysteine-induced fatty liver.

Authors:  Cheng Ji; Masao Shinohara; Dennis Vance; Tin Aung Than; Murad Ookhtens; Christine Chan; Neil Kaplowitz
Journal:  Alcohol Clin Exp Res       Date:  2008-06       Impact factor: 3.455

10.  Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial.

Authors:  Manal F Abdelmalek; Schuyler O Sanderson; Paul Angulo; Consuelo Soldevila-Pico; Chen Liu; Joy Peter; Jill Keach; Matt Cave; Theresa Chen; Craig J McClain; Keith D Lindor
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

View more
  30 in total

1.  Experimental models of non-alcoholic fatty liver disease in rats.

Authors:  Otto Kucera; Zuzana Cervinkova
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Effects of post-weaning diet on metabolic parameters and DNA methylation status of the cryptic promoter in the A(vy) allele of viable yellow mice.

Authors:  Denise A Warzak; Sarah A Johnson; Mark R Ellersieck; R Michael Roberts; Xiang Zhang; Shuk-Mei Ho; Cheryl S Rosenfeld
Journal:  J Nutr Biochem       Date:  2015-02-26       Impact factor: 6.048

3.  Effect of a trans fatty acid-enriched diet on biochemical and inflammatory parameters in Wistar rats.

Authors:  Rafael Longhi; Roberto Farina Almeida; Letiane Machado; Maria Marta Medeiros Frescura Duarte; Débora Guerini Souza; Priscila Machado; Adriano Martimbianco de Assis; André Quincozes-Santos; Diogo Onofre Souza
Journal:  Eur J Nutr       Date:  2016-01-11       Impact factor: 5.614

4.  Betaine Alleviates High-Fat Diet-Induced Disruptionof Hepatic Lipid and Iron Homeostasis in Mice.

Authors:  Yanlin Li; Wenduo Jiang; Yue Feng; Lei Wu; Yimin Jia; Ruqian Zhao
Journal:  Int J Mol Sci       Date:  2022-06-03       Impact factor: 6.208

5.  Rectification of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease.

Authors:  Xiaobing Dou; Yongliang Xia; Jing Chen; Ying Qian; Songtao Li; Ximei Zhang; Zhenyuan Song
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 6.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

7.  High-Mobility Group Box-1 Is Associated With Obesity, Inflammation, and Subclinical Cardiovascular Risk Among Young Adults: A Longitudinal Cohort Study.

Authors:  Li Chen; Haidong Zhu; Shaoyong Su; Gregory Harshfield; Jennifer Sullivan; Clinton Webb; James A Blumenthal; Xiaoling Wang; Ying Huang; Frank A Treiber; Gaston Kapuku; Wenjun Li; Yanbin Dong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-08-20       Impact factor: 8.311

Review 8.  Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests.

Authors:  Mojgan Masoodi; Amalia Gastaldelli; Tuulia Hyötyläinen; Enara Arretxe; Cristina Alonso; Melania Gaggini; Julia Brosnan; Quentin M Anstee; Oscar Millet; Pablo Ortiz; Jose M Mato; Jean-Francois Dufour; Matej Orešič
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-09-10       Impact factor: 46.802

9.  In ovo injection of betaine alleviates corticosterone-induced fatty liver in chickens through epigenetic modifications.

Authors:  Yun Hu; Qinwei Sun; Jie Liu; Yimin Jia; Demin Cai; Abdulrahman A Idriss; Nagmeldin A Omer; Ruqian Zhao
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

10.  Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.

Authors:  Wenjing Zeng; Wen Shan; Lili Gao; Dongyan Gao; Yan Hu; Guangzhi Wang; Ning Zhang; Zhenlu Li; Xiaofeng Tian; Wei Xu; Jinyong Peng; Xiaochi Ma; Jihong Yao
Journal:  Sci Rep       Date:  2015-11-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.